Reproductive-rights advocates are pushing back against the review of the abortion medication mifepristone ordered by Health ...

The action establishes belzutifan as the only approved oral therapy for PPGL. The approval stipulates use in adults and children 12 years or older with locally advanced, unresectable, or metastatic ...

The top 25 stocks in the S&P 500 by weight are the largest, most influential companies in the index. The S&P 500 is widely considered to be one of the best measures of stock market performance and ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

The US Food and Drug Administration (FDA) has approved belzutifan (Welireg, Merck) for adult and pediatric patients aged 12 ...